Transcept Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2012 Financial Results

Published: Feb 28, 2013

POINT RICHMOND, Calif., Feb. 27, 2013 /PRNewswire/ – Transcept Pharmaceuticals, Inc. (TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced financial results for the three and twelve months ended December 31, 2012.

Back to news